Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | 8 | 1 | 1 | 0 | €114.60 | €147.56 | 28.761% |
| Universal Health Services B | 8 | 3 | 1 | 0 | €174.00 | €167.76 | -3.585% |
| Agios Pharmaceuticals Inc. | 7 | 0 | 1 | 0 | €44.00 | €48.75 | 10.794% |
| Amicus Therapeutics Inc. | 7 | 0 | 4 | 0 | €9.65 | €17.64 | 82.774% |
| Codexis Inc. | 7 | 2 | 2 | 0 | €3.24 | €8.36 | 157.717% |
| Adverum Biotechnologies Inc. | 7 | 0 | 1 | 0 | €1.38 | €5.60 | 305.913% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €2.54 | €12.21 | 380.744% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 2 | 0 | €2.17 | €4.39 | 102.178% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Syros Pharmaceuticals Inc. | 6 | 1 | 1 | 0 | €4.88 | €13.60 | 178.637% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €5.74 | €19.50 | 239.695% |
| Myriad Genetics | 5 | 3 | 1 | 1 | €20.60 | €23.08 | 12.026% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €2.11 | €8.35 | 295.118% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.98 | €6.45 | 226.549% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €24.20 | €28.29 | 16.904% |
| Quest Diagnostics Inc. | 5 | 0 | 1 | 0 | €131.00 | €144.44 | 10.263% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.80 | €29.29 | 13.538% |
| Cerus Corp. | 4 | 0 | 0 | 0 | €1.62 | €3.26 | 101.006% |
| Abeona Therapeutics Inc. | 4 | 1 | 1 | 0 | €3.92 | €33.73 | 760.418% |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €5.75 | - | - |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Cytosorbents Corp. | 4 | 0 | 1 | 0 | €0.83 | €3.74 | 351.098% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €221.50 | €315.00 | 42.212% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.26 | €3.70 | 192.953% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €15.00 | €30.00 | 100.000% |